Scholarlink

<p>Intermediate CAG repeats from 29 to 33 in the <i>ATXN2</i> gene contributes to the risk of amyotrophic lateral sclerosis (ALS) in European and Asian populations. In this study, 148 ALS patients of multiethnic descent: Chinese (56.1%), Malay (24.3%), Indian (12.8%), others (6.8%) and 100 neurologically normal controls were screened for the <i>ATXN2</i> CAG repeat expansion. The most common repeat length in both the controls and patients was 22. No familial ALS patients were positive for the intermediate repeat sizes (29–33), while four sporadic patients (2.8%) were positive, with one harbouring a rare <i>ATXN2</i> homozygous 32 repeat expansion, and a likely pathogenic variant in <i>SPAST</i>. All four patients had limb-onset ALS. Despite representing the smallest ethnic group in our patient cohort, three of the four patients with intermediate repeat sizes were of Indian ancestry. This study, which is the first in Malaysia and Southeast Asia, shows that <i>ATXN2</i> intermediate risk expansions are relevant to ALS in these populations and will help to inform future genetic testing strategies in the clinic.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

ATXN2 polyglutamine intermediate repeats length expansions in Malaysian patients with amyotrophic lateral sclerosis (ALS)

  • 期刊论文

  • 发表日期：

    2025年1月13日

查看全文
  • Suzanna Edgar,
  • Nurul Angelyn Zulhairy-Liong,
  • Melina Ellis,
  • Shuchi Trivedi,
  • Danqing Zhu,
  • Jeffrey Ochieng Odongo,
  • Khean-Jin Goh,
  • David Paul Capelle,
  • Nortina Shahrizaila,
  • Marina L. Kennerson,
  • Azlina Ahmad-Annuar

摘要

Intermediate CAG repeats from 29 to 33 in the ATXN2 gene contributes to the risk of amyotrophic lateral sclerosis (ALS) in European and Asian populations. In this study, 148 ALS patients of multiethnic descent: Chinese (56.1%), Malay (24.3%), Indian (12.8%), others (6.8%) and 100 neurologically normal controls were screened for the ATXN2 CAG repeat expansion. The most common repeat length in both the controls and patients was 22. No familial ALS patients were positive for the intermediate repeat sizes (29–33), while four sporadic patients (2.8%) were positive, with one harbouring a rare ATXN2 homozygous 32 repeat expansion, and a likely pathogenic variant in SPAST. All four patients had limb-onset ALS. Despite representing the smallest ethnic group in our patient cohort, three of the four patients with intermediate repeat sizes were of Indian ancestry. This study, which is the first in Malaysia and Southeast Asia, shows that ATXN2 intermediate risk expansions are relevant to ALS in these populations and will help to inform future genetic testing strategies in the clinic.